CPM and colorectal cancer: Mainly, miR-146a-5p promoted the growth of human osteosarcoma by targeting the ZNRF3/GSK3β/β-catenin pathway [43] and enhanced the migration and invasion of human colorectal cancer cells by targeting the carboxypeptidase M/src-FAK pathway [44].